Clinical Trial Update: A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study of a recombinant hGM-CSF–expressing herpes simplex virus for cancer treatment has completed Phase 1, indicating initial safety and dosing data f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer
• Lung Cancer
• Melanoma
• Pancreatic Cancer

Drugs mentioned

• Recombinant hGM-CSF Herpes Simplex Virus

Snippet

Sponsor: OrienGene Biotechnology Ltd. | Conditions: Melanoma, Liver Cancer | Phase 1 | Status: COMPLETED